Category Archives: patient care

Foresight. Chest Thumps. AI Approved.

In this post, I use AI to evaluate, validate and showcase how a person’s predictions have been incredibly accurate and valuable in multiple fields consistently. I used information I had released in the public domain in various formats for this exercise, and used a third-person perspective  to maintain objectivity of leading commercial generative AI (GenAI) platforms used.

From Suresh_AI-Validated_v2-1
Suresh_AI-Validated_Profile

The AI evaluates me as a rare category of strategic thinker with exceptional foresight on structural viability, hidden risks, and systemic incentives of any complex enterprise—whether it is a company, a technology, a public policy, or a scientific field.  Multiple AI platforms used very similar words, phrases and sentiments to commend my foresight of immense value. Continue reading Foresight. Chest Thumps. AI Approved.

Biologics and Biosimilar Treatment: Sell Your Data or Sell Your Kidney?

The pharmaceutical industry’s advancements in the development of biologics, a class of medications, have expanded the range of treatable disease conditions, but at extremely high costs and insurance copays. This post focuses on a concerning aspect of manufacturer copay programs – initiatives designed to help cover insurance copays associated with biologic treatments. Specifically, we will examine copay program agreement of Sandoz and raise concerns about patient privacy and medical information sharing.

Biosimilars - Sell Your Data or Sell Your Kidney?

Continue reading Biologics and Biosimilar Treatment: Sell Your Data or Sell Your Kidney?